Gregory A Freshwater, PA-C | |
710 Wellington Ave, Grand Junction, CO 81501-6123 | |
(970) 298-7106 | |
(970) 298-7177 |
Full Name | Gregory A Freshwater |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Location | 710 Wellington Ave, Grand Junction, Colorado |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043393978 | NPI | - | NPPES |
02589737 | Medicaid | CO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | 2205 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Gregory A Freshwater, PA-C 710 Wellington Ave, Po Box 62, Grand Junction, CO 81501-6123 Ph: (970) 298-7106 | Gregory A Freshwater, PA-C 710 Wellington Ave, Grand Junction, CO 81501-6123 Ph: (970) 298-7106 |
News Archive
In an important step toward developing an effective malaria vaccine, the Bill & Melinda Gates Foundation has announced a $107.6 million grant to the PATH Malaria Vaccine Initiative (MVI) to extend the public-private partnership between MVI and GlaxoSmithKline Biologicals (GSK Bio) to develop GSK Bio's malaria vaccine for children in Africa.
Bederra Corporation, a Houston, Texas-based, diversified medical services provider announced today that it is in preliminary discussions to acquire a Home Healthcare Company.
Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted the Company's late-stage antibiotic candidate ceftolozane/tazobactam (CXA-201) Fast Track status in the previously granted Qualified Infectious Disease Product indications, Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia and Complicated Urinary Tract Infections.
Many serious diseases such as malaria or AIDS present a major challenge for medicine because the causative pathogens use the same strategy although they are completely different: By camouflaging themselves they evade the immune system.
ADVENTRX Pharmaceuticals, Inc. today announced it has submitted a request to the U.S. Food and Drug Administration (FDA) to schedule a meeting for the purpose of discussing its product candidate ANX-514 (docetaxel emulsion for injection). The FDA is expected to set the meeting date within 60 days of receiving the request from ADVENTRX.
› Verified 3 days ago
Valerie H Mcelroy, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2643 Patterson Rd, Ste 503, Grand Junction, CO 81506 Phone: 970-245-2400 | |
Amalia Michalek, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2440 N 11th St, Grand Junction, CO 81501 Phone: 970-243-0900 | |
Michael Lee Hanson, PAC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2643 Patterson Rd, Suite 503, Grand Junction, CO 81506 Phone: 970-245-2400 Fax: 970-242-9092 | |
Emmalee Vittetoe, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1100 North Ave, Grand Junction, CO 81501 Phone: 970-646-2045 | |
Evan Fischer, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1100 North Ave, Grand Junction, CO 81501 Phone: 970-248-2263 | |
Mr. Ryan Glynn Goodman, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1060 Orchard Ave, Grand Junction, CO 81501 Phone: 970-644-3740 |